Related Experiment Videos
Endogenous endothelins mediate increased acidification in remnant kidneys
1Texas Tech University Health Sciences Center, Texas Tech University School of Medicine, Lubbock, Texas.
Journal of the American Society of Nephrology : JASN
|August 24, 2001
Summary
Endothelins (ET) play a key role in acid retention in remnant kidneys. Blocking ET receptors with bosentan reduced acid excretion and improved blood base excess in nephrectomized rats.
Area of Science:
- Nephrology
- Renal Physiology
- Endocrinology
Background:
- Dietary acid intake increases renal acidification, mediated by endothelins (ET).
- Reduced renal mass, as seen in nephrectomized (Nx) animals, leads to increased urinary ET-1 excretion.
- This study investigated the role of ET in renal acidification in remnant kidneys.
Purpose of the Study:
- To test the hypothesis that endothelins mediate increased renal acidification in remnant kidneys.
- To determine the effect of ET receptor antagonism on acid-base balance in Nx rats.
Main Methods:
- Rats underwent 5/6 nephrectomy (Nx) or sham surgery.
- Renal ET-1 content and urinary ET-1 excretion were measured.
- In situ proximal and distal tubule bicarbonate reabsorption was assessed.
- The ET(A/B) receptor antagonist bosentan was administered orally to Nx rats.
Main Results:
- Nx animals showed significantly higher renal ET-1 content and urinary ET-1 excretion compared to controls.
- Despite similar urinary net acid excretion, Nx animals exhibited increased proximal and distal tubule bicarbonate reabsorption.
- Bosentan administration significantly decreased urinary net acid excretion and improved blood base excess in Nx animals.
- The effects of bosentan were attributed to reduced bicarbonate reabsorption in both proximal and distal tubules.
Conclusions:
- Endogenous endothelins mediate increased urinary acid excretion in remnant kidneys of Nx animals.
- ET receptor blockade with bosentan ameliorates acid retention in reduced renal mass models.
- Targeting the endothelin system may offer therapeutic potential for managing acid-base disorders in chronic kidney disease.